• Skip to primary navigation
  • Skip to main content
Allumeros

Allumeros

BioScience LLC

  • Home
  • About
  • Focus
  • Strategy
  • Innovation
  • Contact

Strategic Vision

Establishing, Retaining and Growing Value

Our ultimate objective is to establish PNT as a widely used theranostic platform – delivered through individual, segment focused operating business – maximizing therapeutic coverage, the value of the technology and return to our investors.

We envision PNT as a first-line treatment option for a wide spectrum of critical and difficult to treat conditions. In its full theranostic application PNT will cross therapeutic segments and is anticipated to deliver a safe, minimally invasive, highly effective and economic therapy.

 

 

In pursuit of this goal we are implementing a clear two stage approach to the market.


Strategic Execution

Phase 1  –  Focus on three key indications in a multi-billion dollar market

Establish the performance and value of PNT as an adjunct treatment with surgery. Demonstrate effectiveness and improved outcomes.

Phase 2  –  Broaden the clinical utility of PNT

Establish PNT as an effective first-line minimally invasive treatment.
Expand into other indications and therapeutic segments.

 

Maximizes shareholder value – ensures executional focus

Want to learn more?



Contact us

Copyright © Allumeros Inc 2019. All Rights Reserved Privacy Policy · Terms of Use · Design by Reach Creative